The Journal of Immunology, Vol 153, Issue 6 2671-2680, Copyright © 1994 by American Association of Immunologists

ARTICLES

Activation of human monocytes by the pineal hormone melatonin

KM Morrey, JA McLachlan, CD Serkin and O Bakouche
Department of Molecular Pharmacology and Biologic Chemistry, Northwestern University Medical School, Chicago, IL 60611.

To determine the effects of the pineal hormone melatonin on human monocytes, human monocytes were activated by different concentrations of melatonin. Above the activation threshold of 5 x 10(-11) M, melatonin was able to induce the cytotoxicity of human monocytes, the secretion of IL-1, and the production of reactive oxygen intermediates. Melatonin and LPS seemed to have a synergistic effect on human monocyte activation. Indeed, below their respective monocyte activation threshold (5 x 10(-11) M and 0.625 ng/ml), melatonin (10(-12) M) in association with LPS (0.2 ng/ml) was able to induce cytotoxicity, IL-1 secretion, and reactive oxygen intermediates production. Melatonin alone at 10(-12) M or LPS alone at 0.2 ng/ml did not activate monocytes. Furthermore, melatonin was able to prime the monocytes for a subsequent activation by LPS. When monocytes were activated by LPS (0.25 ng/ml) at the time that they were plated and then activated by melatonin (10(-12) M) 8 h later, no IL-1 secretion and no cytotoxicity were detected. However, when the cells were first activated by melatonin (10(-12) M), and then 8 h later by LPS (0.25 ng/ml), IL-1 secretion and monocyte cytotoxicity were observed. Above its monocyte activation threshold, melatonin induces both cell-associated IL-1 alpha and IL-1 beta activities. Below this activation threshold, i.e., at 10(- 12) M, melatonin does not induce the cell-associated IL-1 alpha and IL- 1 beta activities, but does induce the mRNA for both IL-1 (alpha and beta). It seems that melatonin activates monocytes through protein kinase C. These data suggest that melatonin activates monocytes and induces their cytotoxic properties, along with the IL-1 secretion.

This article has been cited by other articles:

				Y. Adachi, A. L. Kindzelskii, A. R. Petty, J.-B. Huang, N. Maeda, S. Yotsumoto, Y. Aratani, N. Ohno, and H. R. Petty IFN-{gamma} Primes RAW264 Macrophages and Human Monocytes for Enhanced Oxidant Production in Response to CpG DNA via Metabolic Signaling: Roles of TLR9 and Myeloperoxidase Trafficking. J. Immunol., April 15, 2006; 176(8): 5033 - 5040. [Abstract] [Full Text] [PDF]

				A. J. Jimenez-Caliani, S. Jimenez-Jorge, P. Molinero, J. M. Fernandez-Santos, I. Martin-Lacave, A. Rubio, J. M. Guerrero, and C. Osuna Sex-Dependent Effect of Melatonin on Systemic Erythematosus Lupus Developed in Mrl/Mpj-Faslpr Mice: It Ameliorates the Disease Course in Females, whereas It Exacerbates It in Males Endocrinology, April 1, 2006; 147(4): 1717 - 1724. [Abstract] [Full Text] [PDF]

				M Cutolo and G J M Maestroni The melatonin-cytokine connection in rheumatoid arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1109 - 1111. [Full Text] [PDF]

				A. Carrillo-Vico, P. J. Lardone, J. M. Fernandez-Santos, I. Martin-Lacave, J. R. Calvo, M. Karasek, and J. M. Guerrero Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 992 - 1000. [Abstract] [Full Text] [PDF]

				B. del Rio, J. M. G. Pedrero, C. Martinez-Campa, P. Zuazua, P. S. Lazo, and S. Ramos Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor {alpha} via Calmodulin J. Biol. Chem., September 10, 2004; 279(37): 38294 - 38302. [Abstract] [Full Text] [PDF]

				E. Martins Jr., A. C. F. Ferreira, A. L. Skorupa, S. C. Afeche, J. Cipolla-Neto, and L. F. B. P. Costa Rosa Tryptophan consumption and indoleamines production by peritoneal cavity macrophages J. Leukoc. Biol., June 1, 2004; 75(6): 1116 - 1121. [Abstract] [Full Text] [PDF]

				M Cutolo, B Seriolo, C Craviotto, C Pizzorni, and A Sulli Circadian rhythms in RA Ann Rheum Dis, July 1, 2003; 62(7): 593 - 596. [Full Text] [PDF]

				I. Cloez-Tayarani, A.-F. Petit-Bertron, H. D. Venters, and J.-M. Cavaillon Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors Int. Immunol., February 1, 2003; 15(2): 233 - 240. [Abstract] [Full Text] [PDF]

				L. F. Olsen, U. Kummer, A. L. Kindzelskii, and H. R. Petty A Model of the Oscillatory Metabolism of Activated Neutrophils Biophys. J., January 1, 2003; 84(1): 69 - 81. [Abstract] [Full Text] [PDF]

				Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]

				A. GARCÍA RATO, J. GARCÍA PEDRERO, M. A. MARTÍNEZ, B. DEL RIO, P. S. LAZO, and S. RAMOS Melatonin blocks the activation of estrogen receptor for DNA binding FASEB J, May 1, 1999; 13(8): 857 - 868. [Abstract] [Full Text]

				I. Wiid, E. Hoal-van Helden, D. Hon, C. Lombard, and P. van Helden Potentiation of Isoniazid Activity against Mycobacterium tuberculosis by Melatonin Antimicrob. Agents Chemother., April 1, 1999; 43(4): 975 - 977. [Abstract] [Full Text]

				M. J. Barjavel, Z. Mamdouh, N. Raghbate, and O. Bakouche Differential Expression of the Melatonin Receptor in Human Monocytes J. Immunol., February 1, 1998; 160(3): 1191 - 1197. [Abstract] [Full Text] [PDF]

				E. Gilad, H. Matzkin, and N. Zisapel Inactivation of Melatonin Receptors by Protein Kinase C in Human Prostate Epithelial Cells Endocrinology, October 1, 1997; 138(10): 4255 - 4261. [Abstract] [Full Text] [PDF]